ONL Therapeutics, Inc. logo

ONL Therapeutics, Inc.

ONL Therapeutics is pioneering an entirely new approach to preserving sight and halting vision loss associated with a range of retinal disease. The company is advancing a breakthrough technology designed to prevent the death of key retinal cells caused by the activation of the natural Fas pathway.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.onltherapeutics.com
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address
1600 Huron Pkwy Building 520, Second Floor, MI, 48109
Ann Arbor
United States
Email
Contact Number
+1 734-998-8339

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/onl-therapeutics” connections=”true” suffix=””]